I guess I stumbled into some good timing recently in writing about the role of short squeezes in the valuations of Insuretech stocks as short squeezes have become the story of 2021 so far. Last week, I wrote about the prominent short seller Andrew Left, of Citron, who targeted LMND Continue Reading